| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.53e-08 | 343 | 41 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.86e-08 | 52 | 41 | 5 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.21e-07 | 26 | 41 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.02e-07 | 459 | 41 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | channel activity | 9.28e-07 | 525 | 41 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 9.43e-07 | 526 | 41 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 2.27e-06 | 13 | 41 | 3 | GO:0045028 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.88e-06 | 14 | 41 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.96e-06 | 465 | 41 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 6.36e-06 | 664 | 41 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 6.42e-06 | 18 | 41 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 1.20e-05 | 22 | 41 | 3 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 1.20e-05 | 22 | 41 | 3 | GO:0001614 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CYB561D1 TRPA1 KCNQ4 ABCA8 SCN1A PIEZO1 RYR2 SCN4A TRPM2 SCN8A SCN9A | 1.79e-05 | 1180 | 41 | 11 | GO:0022857 |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.02e-05 | 26 | 41 | 3 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.54e-05 | 171 | 41 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.62e-05 | 793 | 41 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.45e-05 | 627 | 41 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.47e-05 | 31 | 41 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | transporter activity | CYB561D1 TRPA1 KCNQ4 ABCA8 SCN1A PIEZO1 RYR2 SCN4A TRPM2 SCN8A SCN9A | 4.06e-05 | 1289 | 41 | 11 | GO:0005215 |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 4.10e-05 | 5 | 41 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.20e-05 | 33 | 41 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.75e-05 | 334 | 41 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.31e-04 | 758 | 41 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 3.69e-04 | 14 | 41 | 2 | GO:0032454 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 6.16e-04 | 18 | 41 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.40e-03 | 27 | 41 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.42e-03 | 1353 | 41 | 9 | GO:0004888 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.50e-03 | 28 | 41 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.50e-03 | 28 | 41 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.84e-03 | 31 | 41 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.96e-03 | 884 | 41 | 7 | GO:0004930 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.96e-03 | 32 | 41 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | snoRNA binding | 2.21e-03 | 34 | 41 | 2 | GO:0030515 | |
| GeneOntologyMolecularFunction | pattern recognition receptor activity | 2.34e-03 | 35 | 41 | 2 | GO:0038187 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.35e-03 | 129 | 41 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.62e-03 | 37 | 41 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.96e-03 | 140 | 41 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.66e-03 | 151 | 41 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | demethylase activity | 3.68e-03 | 44 | 41 | 2 | GO:0032451 | |
| GeneOntologyMolecularFunction | heme binding | 3.87e-03 | 154 | 41 | 3 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 4.61e-03 | 164 | 41 | 3 | GO:0046906 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 6.16e-03 | 182 | 41 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 6.35e-03 | 184 | 41 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.24e-03 | 193 | 41 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.65e-03 | 197 | 41 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 7.88e-03 | 65 | 41 | 2 | GO:0016706 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 8.12e-03 | 614 | 41 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 9.09e-03 | 70 | 41 | 2 | GO:0003777 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.32e-02 | 85 | 41 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.69e-02 | 97 | 41 | 2 | GO:0004896 | |
| GeneOntologyMolecularFunction | antioxidant activity | 1.69e-02 | 97 | 41 | 2 | GO:0016209 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.73e-02 | 98 | 41 | 2 | GO:0051213 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.44e-07 | 62 | 41 | 5 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.56e-07 | 63 | 41 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 7.56e-07 | 36 | 41 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.90e-07 | 87 | 41 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 1.10e-06 | 93 | 41 | 5 | GO:0086003 | |
| GeneOntologyBiologicalProcess | G protein-coupled purinergic nucleotide receptor signaling pathway | 2.06e-06 | 13 | 41 | 3 | GO:0035589 | |
| GeneOntologyBiologicalProcess | action potential | 2.69e-06 | 201 | 41 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.77e-06 | 112 | 41 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.13e-06 | 127 | 41 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | TRPA1 P2RY12 KCNQ4 SCN1A PIEZO1 RYR2 SCN4A TRPM2 SCN8A SCN9A | 1.16e-05 | 942 | 41 | 10 | GO:0098655 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.27e-05 | 153 | 41 | 5 | GO:0030048 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 1.47e-05 | 75 | 41 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.88e-05 | 166 | 41 | 5 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.94e-05 | 167 | 41 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | blood circulation | 3.47e-05 | 648 | 41 | 8 | GO:0008015 | |
| GeneOntologyBiologicalProcess | purinergic nucleotide receptor signaling pathway | 3.82e-05 | 33 | 41 | 3 | GO:0035590 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPA1 P2RY12 KCNQ4 SCN1A PIEZO1 RYR2 SCN4A TRPM2 SCN8A SCN9A | 4.94e-05 | 1115 | 41 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 5.54e-05 | 208 | 41 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 6.60e-05 | 922 | 41 | 9 | GO:0098662 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | TRPA1 P2RY12 KCNQ4 SCN1A PIEZO1 RYR2 SCN4A TRPM2 SCN8A SCN9A | 6.74e-05 | 1157 | 41 | 10 | GO:0006812 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 6.78e-05 | 217 | 41 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | circulatory system process | 8.27e-05 | 733 | 41 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 8.51e-05 | 43 | 41 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 9.65e-05 | 121 | 41 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 1.04e-04 | 559 | 41 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.05e-04 | 238 | 41 | 5 | GO:0050954 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.23e-04 | 1000 | 41 | 9 | GO:0030001 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.25e-04 | 247 | 41 | 5 | GO:0009612 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.30e-04 | 400 | 41 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.40e-04 | 1017 | 41 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.75e-04 | 1048 | 41 | 9 | GO:0014070 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 1.76e-04 | 266 | 41 | 5 | GO:0019722 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.98e-04 | 57 | 41 | 3 | GO:0050974 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.06e-04 | 275 | 41 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 2.51e-04 | 12 | 41 | 2 | GO:0071421 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPA1 P2RY12 KCNQ4 SCN1A PIEZO1 RYR2 SCN4A TRPM2 SCN8A SCN9A | 2.78e-04 | 1374 | 41 | 10 | GO:0006811 |
| GeneOntologyBiologicalProcess | heart contraction | 2.98e-04 | 298 | 41 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | manganese ion transport | 3.46e-04 | 14 | 41 | 2 | GO:0006828 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 3.46e-04 | 14 | 41 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin activation | 3.46e-04 | 14 | 41 | 2 | GO:0033625 | |
| GeneOntologyBiologicalProcess | heart process | 3.52e-04 | 309 | 41 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 3.80e-04 | 173 | 41 | 4 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 3.97e-04 | 175 | 41 | 4 | GO:0009582 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 4.98e-04 | 722 | 41 | 7 | GO:0051606 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 5.59e-04 | 81 | 41 | 3 | GO:0098900 | |
| GeneOntologyBiologicalProcess | muscle system process | 6.91e-04 | 547 | 41 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | regulation of integrin activation | 7.16e-04 | 20 | 41 | 2 | GO:0033623 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 7.90e-04 | 21 | 41 | 2 | GO:0071318 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion mediated by integrin | 9.50e-04 | 23 | 41 | 2 | GO:0033630 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.00e-03 | 224 | 41 | 4 | GO:0007204 | |
| GeneOntologyBiologicalProcess | outer dynein arm assembly | 1.03e-03 | 24 | 41 | 2 | GO:0036158 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 1.17e-03 | 605 | 41 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 1.18e-03 | 1361 | 41 | 9 | GO:0009628 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 1.19e-03 | 105 | 41 | 3 | GO:0019233 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of pain | 1.22e-03 | 26 | 41 | 2 | GO:0050966 | |
| GeneOntologyBiologicalProcess | integrin activation | 1.51e-03 | 29 | 41 | 2 | GO:0033622 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 2.34e-03 | 133 | 41 | 3 | GO:0007200 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.97e-08 | 17 | 41 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.92e-07 | 29 | 41 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 6.13e-06 | 235 | 41 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 8.85e-05 | 378 | 41 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | outer dynein arm | 2.45e-04 | 12 | 41 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.09e-04 | 523 | 41 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | basal plasma membrane | 6.15e-04 | 354 | 41 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | transporter complex | 6.63e-04 | 550 | 41 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | node of Ranvier | 6.97e-04 | 20 | 41 | 2 | GO:0033268 | |
| GeneOntologyCellularComponent | basal part of cell | 8.26e-04 | 378 | 41 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.09e-03 | 25 | 41 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | axon initial segment | 1.47e-03 | 29 | 41 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | Z disc | 3.22e-03 | 151 | 41 | 3 | GO:0030018 | |
| HumanPheno | Complex febrile seizure | 2.02e-05 | 16 | 18 | 3 | HP:0011172 | |
| MousePheno | decreased paired-pulse ratio | 3.23e-05 | 4 | 33 | 2 | MP:0014253 | |
| MousePheno | abnormal paired-pulse ratio | 1.13e-04 | 7 | 33 | 2 | MP:0014252 | |
| MousePheno | ventricular fibrillation | 1.13e-04 | 7 | 33 | 2 | MP:0006110 | |
| Domain | Ion_trans_dom | 9.82e-11 | 114 | 40 | 8 | IPR005821 | |
| Domain | Ion_trans | 9.82e-11 | 114 | 40 | 8 | PF00520 | |
| Domain | Na_channel_asu | 3.75e-09 | 10 | 40 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 3.75e-09 | 10 | 40 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 3.75e-09 | 10 | 40 | 4 | PF06512 | |
| Domain | Na_trans_cytopl | 1.81e-07 | 6 | 40 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 1.81e-07 | 6 | 40 | 3 | IPR024583 | |
| Domain | Channel_four-helix_dom | 6.56e-06 | 57 | 40 | 4 | IPR027359 | |
| Domain | - | 6.56e-06 | 57 | 40 | 4 | 1.20.120.350 | |
| Domain | IQ | 1.58e-05 | 71 | 40 | 4 | PF00612 | |
| Domain | IQ | 2.66e-05 | 81 | 40 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 4.04e-05 | 90 | 40 | 4 | IPR000048 | |
| Domain | IQ | 4.59e-05 | 93 | 40 | 4 | PS50096 | |
| Domain | EF-hand-dom_pair | 3.51e-04 | 287 | 40 | 5 | IPR011992 | |
| Domain | 7tm_1 | 5.24e-04 | 677 | 40 | 7 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.62e-04 | 685 | 40 | 7 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 5.91e-04 | 691 | 40 | 7 | PS50262 | |
| Domain | GPCR_Rhodpsn | 5.97e-04 | 692 | 40 | 7 | IPR000276 | |
| Domain | JmjC | 1.20e-03 | 24 | 40 | 2 | PF02373 | |
| Domain | JMJC | 2.13e-03 | 32 | 40 | 2 | PS51184 | |
| Domain | JmjC_dom | 2.13e-03 | 32 | 40 | 2 | IPR003347 | |
| Domain | JmjC | 2.26e-03 | 33 | 40 | 2 | SM00558 | |
| Domain | GPCR_Rhodpsn_7TM | 2.83e-03 | 670 | 40 | 6 | IPR017452 | |
| Domain | ABC_transporter-like | 5.13e-03 | 50 | 40 | 2 | IPR003439 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.34e-06 | 31 | 38 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.53e-06 | 32 | 38 | 4 | M27455 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 2.94e-06 | 11 | 38 | 3 | MM15049 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 3.91e-06 | 12 | 38 | 3 | M10960 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 9.88e-06 | 16 | 38 | 3 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 9.88e-06 | 16 | 38 | 3 | MM15050 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.56e-05 | 203 | 38 | 6 | M5485 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.43e-05 | 130 | 38 | 5 | M27454 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 6.25e-05 | 260 | 38 | 6 | M39397 | |
| Pathway | WP_PURINERGIC_SIGNALING | 9.32e-05 | 33 | 38 | 3 | M39855 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.34e-04 | 186 | 38 | 5 | MM15994 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 2.53e-04 | 46 | 38 | 3 | M46450 | |
| Pathway | WP_RETT_SYNDROME | 2.87e-04 | 48 | 38 | 3 | M39759 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.04e-04 | 121 | 38 | 4 | M872 | |
| Pathway | WP_GPCRS_NONODORANT | 6.95e-04 | 266 | 38 | 5 | MM15843 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 7.27e-04 | 15 | 38 | 2 | M22002 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 1.73e-03 | 23 | 38 | 2 | MM15279 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.82e-03 | 330 | 38 | 5 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.89e-03 | 333 | 38 | 5 | MM14963 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.37e-03 | 99 | 38 | 3 | MM14910 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.38e-03 | 27 | 38 | 2 | M47755 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.56e-03 | 28 | 38 | 2 | MM14943 | |
| Pathway | WP_DRAVET_SYNDROME | 2.56e-03 | 28 | 38 | 2 | M45519 | |
| Pathway | REACTOME_TRP_CHANNELS | 2.56e-03 | 28 | 38 | 2 | M27241 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 2.74e-03 | 29 | 38 | 2 | MM14934 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.88e-03 | 106 | 38 | 3 | M27200 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 2.93e-03 | 30 | 38 | 2 | M27566 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 3.33e-03 | 32 | 38 | 2 | MM15850 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 3.98e-03 | 35 | 38 | 2 | M47969 | |
| Pubmed | 2.54e-10 | 9 | 43 | 4 | 16382098 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.97e-08 | 139 | 43 | 6 | 16985003 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 3.51e-08 | 6 | 43 | 3 | 23652591 | |
| Pubmed | Expression of P2Y(6) receptors in the developing mouse skeletal muscle and after injury and repair. | 6.14e-08 | 7 | 43 | 3 | 21413988 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 15746173 | ||
| Pubmed | 4.99e-07 | 13 | 43 | 3 | 15123669 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 1.49e-06 | 2 | 43 | 2 | 37901435 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 1.49e-06 | 2 | 43 | 2 | 26410685 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28800362 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33411788 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 31943325 | ||
| Pubmed | Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. | 1.49e-06 | 2 | 43 | 2 | 20952684 | |
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.49e-06 | 2 | 43 | 2 | 27174182 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 14645014 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 1.49e-06 | 2 | 43 | 2 | 37665666 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 17881658 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 16843602 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 33895391 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 32845893 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 20398327 | ||
| Pubmed | Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. | 4.48e-06 | 3 | 43 | 2 | 20664064 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 20038812 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 28518218 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 4.48e-06 | 3 | 43 | 2 | 24704313 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 25575683 | ||
| Pubmed | Loss of nucleotide regulation of epithelial chloride transport in the jejunum of P2Y4-null mice. | 4.48e-06 | 3 | 43 | 2 | 12644577 | |
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 4.48e-06 | 3 | 43 | 2 | 28117367 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 31285762 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 17928448 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 4.48e-06 | 3 | 43 | 2 | 31054517 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15302875 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17537961 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 35031483 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 29526734 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 23593242 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22057273 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 29578003 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21156207 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22260870 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22199395 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 16603237 | ||
| Pubmed | Models for discovery of targeted therapy in genetic epileptic encephalopathies. | 8.94e-06 | 4 | 43 | 2 | 28742937 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 25972159 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 8812438 | ||
| Pubmed | Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells. | 1.49e-05 | 5 | 43 | 2 | 19549686 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.49e-05 | 5 | 43 | 2 | 22875929 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 32208171 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 17724025 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 27494721 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 16029194 | ||
| Pubmed | Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. | 2.23e-05 | 6 | 43 | 2 | 27797339 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 32679061 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 23711479 | ||
| Pubmed | Gene-environment interaction in the etiology of mathematical ability using SNP sets. | 3.12e-05 | 7 | 43 | 2 | 20978832 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 3.12e-05 | 7 | 43 | 2 | 25818041 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 15272007 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 31178125 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 25101983 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 9412493 | ||
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 5.35e-05 | 9 | 43 | 2 | 17884088 | |
| Pubmed | ZMYND10 functions in a chaperone relay during axonemal dynein assembly. | 6.68e-05 | 10 | 43 | 2 | 29916806 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 9.78e-05 | 12 | 43 | 2 | 30175250 | |
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 23479225 | ||
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 35904071 | ||
| Pubmed | 1.27e-04 | 638 | 43 | 6 | 31182584 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 9373155 | ||
| Pubmed | Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. | 1.77e-04 | 16 | 43 | 2 | 27721240 | |
| Pubmed | Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia. | 2.26e-04 | 18 | 43 | 2 | 31911949 | |
| Pubmed | 3.09e-04 | 21 | 43 | 2 | 25369838 | ||
| Pubmed | Glucocorticoid receptor is required for foetal heart maturation. | 3.40e-04 | 22 | 43 | 2 | 23595884 | |
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 4.05e-04 | 24 | 43 | 2 | 33884443 | |
| Pubmed | 4.40e-04 | 25 | 43 | 2 | 16382100 | ||
| Pubmed | 4.77e-04 | 529 | 43 | 5 | 14621295 | ||
| Pubmed | 5.14e-04 | 27 | 43 | 2 | 16460286 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 5.79e-04 | 552 | 43 | 5 | 10737800 | |
| Pubmed | Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs. | 5.93e-04 | 29 | 43 | 2 | 11997339 | |
| Pubmed | 7.69e-04 | 33 | 43 | 2 | 30037926 | ||
| Pubmed | 7.69e-04 | 33 | 43 | 2 | 19834762 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 7.69e-04 | 33 | 43 | 2 | 26864203 | |
| Pubmed | 8.11e-04 | 339 | 43 | 4 | 30415952 | ||
| Pubmed | Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. | 1.02e-03 | 38 | 43 | 2 | 19264973 | |
| Interaction | SCN11A interactions | 3.50e-06 | 15 | 41 | 3 | int:SCN11A | |
| Interaction | CACNA1D interactions | 1.54e-05 | 24 | 41 | 3 | int:CACNA1D | |
| Interaction | SNTA1 interactions | 6.07e-05 | 105 | 41 | 4 | int:SNTA1 | |
| Interaction | KIAA2013 interactions | 8.95e-05 | 116 | 41 | 4 | int:KIAA2013 | |
| Interaction | SCN4B interactions | 1.12e-04 | 8 | 41 | 2 | int:SCN4B | |
| Interaction | SCN5A interactions | 1.19e-04 | 47 | 41 | 3 | int:SCN5A | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.15e-09 | 9 | 33 | 4 | 1203 | |
| GeneFamily | Purinergic receptors P2Y | 6.59e-07 | 10 | 33 | 3 | 213 | |
| GeneFamily | Dyneins, axonemal | 4.32e-04 | 17 | 33 | 2 | 536 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 8.70e-04 | 24 | 33 | 2 | 485 | |
| GeneFamily | Transient receptor potential cation channels | 1.19e-03 | 28 | 33 | 2 | 249 | |
| Coexpression | GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP | 1.27e-05 | 194 | 41 | 5 | M4152 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 1.47e-05 | 200 | 41 | 5 | M7841 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.37e-07 | 165 | 43 | 5 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-07 | 173 | 43 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-07 | 176 | 43 | 5 | e08e7a6dd0208acfbb8646d71915af822a64b5de | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-07 | 176 | 43 | 5 | b8264cdda75c5145d8bf8ae00b3e05393fe9a92b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.38e-07 | 176 | 43 | 5 | 4aee9fdada077db7e531684ab938153f84dc8146 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.95e-07 | 183 | 43 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 9.96e-07 | 187 | 43 | 5 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 190 | 43 | 5 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-06 | 190 | 43 | 5 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-05 | 159 | 43 | 4 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 163 | 43 | 4 | e04de78a52cc886623689a913f7852200a77605b | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 163 | 43 | 4 | 8509b87748ec460992ae6cedbb155e1c6f6e2e48 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 166 | 43 | 4 | 6842735750dcb361e4c9844f05233b0fbb879652 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 168 | 43 | 4 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 168 | 43 | 4 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 169 | 43 | 4 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-05 | 169 | 43 | 4 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 2.21e-05 | 171 | 43 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 172 | 43 | 4 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.32e-05 | 173 | 43 | 4 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 176 | 43 | 4 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 176 | 43 | 4 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 176 | 43 | 4 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-05 | 177 | 43 | 4 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-05 | 177 | 43 | 4 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.65e-05 | 179 | 43 | 4 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.71e-05 | 180 | 43 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.77e-05 | 181 | 43 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-05 | 182 | 43 | 4 | 8737142aa4c8301fb5b0ad5bef596471ac316743 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-05 | 182 | 43 | 4 | ecb5624c9074cc6449fad961df54c926c2681d54 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-Zbtb32+_B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-05 | 182 | 43 | 4 | 632014a6e042d09302f4631ca3a1da36af7a7c98 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-05 | 186 | 43 | 4 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-05 | 187 | 43 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.14e-05 | 187 | 43 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.21e-05 | 188 | 43 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.21e-05 | 188 | 43 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 189 | 43 | 4 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 189 | 43 | 4 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 3.27e-05 | 189 | 43 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 190 | 43 | 4 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 191 | 43 | 4 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-05 | 191 | 43 | 4 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-05 | 191 | 43 | 4 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.48e-05 | 192 | 43 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 3.48e-05 | 192 | 43 | 4 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-05 | 193 | 43 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-05 | 193 | 43 | 4 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.55e-05 | 193 | 43 | 4 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.55e-05 | 193 | 43 | 4 | 48ce11778252ae2ef902b30816061b59a3c81695 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-05 | 193 | 43 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.55e-05 | 193 | 43 | 4 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.85e-05 | 197 | 43 | 4 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 198 | 43 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 198 | 43 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | mLN-(5)_Dendritic_cell|mLN / shred on region, Cell_type, and subtype | 4.00e-05 | 199 | 43 | 4 | 4feecf533e29a1a558f1018a2e8f7bfa7b9d3864 | |
| ToppCell | mLN-Dendritic_cell|mLN / Region, Cell class and subclass | 4.00e-05 | 199 | 43 | 4 | 597412beae1324b9c43ca2bb96c4cb645c19f3e9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-05 | 199 | 43 | 4 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.08e-05 | 200 | 43 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.08e-05 | 200 | 43 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.08e-05 | 200 | 43 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Lymphoid-B_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 1.68e-04 | 111 | 43 | 3 | df23af931ce0258ce97d6b4c7125ae1ab16a7eaa | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.72e-04 | 112 | 43 | 3 | 96038a5240b89f2f6fd26ec5403ce1e23b01b266 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Myxofibrosarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.27e-04 | 123 | 43 | 3 | 12b87d06e62f142e18424aae5c87454e78e713f0 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-04 | 128 | 43 | 3 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.80e-04 | 132 | 43 | 3 | b7611c6a5c86908132e7ab3e41d67277e8142db1 | |
| ToppCell | TCGA-Thryoid|World / Sample_Type by Project: Shred V9 | 3.18e-04 | 138 | 43 | 3 | 8cbae2ec9a51712bed5b4e5f9f834ecccb6b7a47 | |
| ToppCell | NS-critical-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.61e-04 | 144 | 43 | 3 | 0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 145 | 43 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-04 | 149 | 43 | 3 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-04 | 149 | 43 | 3 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.31e-04 | 153 | 43 | 3 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.39e-04 | 154 | 43 | 3 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.39e-04 | 154 | 43 | 3 | e3a8a1e63ab345de62bd2e5e54342b00f04ae422 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 156 | 43 | 3 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | 66c011e9de002224f70725dfe8e7871c8d304492 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.82e-04 | 159 | 43 | 3 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.82e-04 | 159 | 43 | 3 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 161 | 43 | 3 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 161 | 43 | 3 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 161 | 43 | 3 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-macrophage|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 162 | 43 | 3 | 0cee9ef405765f3f82d0cd7b8adc88f6e9fdbb5c | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.09e-04 | 162 | 43 | 3 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 163 | 43 | 3 | 2a561aa4518cf52d8470eff083b84f942a2b2b5d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-04 | 164 | 43 | 3 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.27e-04 | 164 | 43 | 3 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-04 | 164 | 43 | 3 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 165 | 43 | 3 | 4cdd80580d5638fd649280ba3893251c2f898f3f | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.37e-04 | 165 | 43 | 3 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 165 | 43 | 3 | c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.37e-04 | 165 | 43 | 3 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 166 | 43 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 166 | 43 | 3 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 166 | 43 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| Drug | AC1L1IZE | 1.66e-07 | 131 | 43 | 6 | CID000004799 | |
| Drug | spiradoline | 1.70e-06 | 46 | 43 | 4 | CID000005620 | |
| Drug | isoproterenol | 3.57e-06 | 669 | 43 | 9 | CID000003779 | |
| Drug | bepridil | 3.90e-06 | 126 | 43 | 5 | CID000002351 | |
| Drug | Zonisamide | 4.19e-06 | 17 | 43 | 3 | DB00909 | |
| Drug | AC1L1IO7 | 1.03e-05 | 72 | 43 | 4 | CID000000194 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.04e-05 | 3 | 43 | 2 | ctd:C561228 | |
| Drug | diethylene glycol | 1.91e-05 | 84 | 43 | 4 | CID000008117 | |
| Drug | AC1L1HK7 | 2.09e-05 | 4 | 43 | 2 | CID000004166 | |
| Drug | NSC7524 | 2.32e-05 | 182 | 43 | 5 | CID000005657 | |
| Drug | PF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A | 3.24e-05 | 195 | 43 | 5 | 6379_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 3.40e-05 | 197 | 43 | 5 | 4585_UP | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A | 3.48e-05 | 198 | 43 | 5 | 3583_UP | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.56e-05 | 199 | 43 | 5 | 3198_UP | |
| Drug | isradipine | 3.79e-05 | 100 | 43 | 4 | CID000003784 | |
| Drug | Ap6A | 4.29e-05 | 36 | 43 | 3 | CID000123694 | |
| Drug | APETx1, Anthopleura elegantissima | 5.20e-05 | 6 | 43 | 2 | ctd:C475726 | |
| Drug | lamotrigine | 6.77e-05 | 116 | 43 | 4 | CID000003878 | |
| Drug | I pN | 7.35e-05 | 43 | 43 | 3 | CID000012276 | |
| Drug | valproate | 7.63e-05 | 381 | 43 | 6 | CID000003121 | |
| Drug | tetraethylammonium | 8.01e-05 | 236 | 43 | 5 | CID000005413 | |
| Drug | aldosterone | 9.56e-05 | 397 | 43 | 6 | CID000005839 | |
| Drug | Mrs2279 | 9.69e-05 | 8 | 43 | 2 | CID005311301 | |
| Drug | lacosamide | 1.30e-04 | 52 | 43 | 3 | CID000219078 | |
| Drug | AC1N1QTU | 1.38e-04 | 53 | 43 | 3 | CID003985498 | |
| Drug | tetradotoxin | 1.44e-04 | 428 | 43 | 6 | CID000020382 | |
| Drug | AC1L1DKE | 1.54e-04 | 55 | 43 | 3 | CID000002388 | |
| Drug | NSC36900 | 1.62e-04 | 56 | 43 | 3 | CID000235484 | |
| Drug | 8-SPT | 1.71e-04 | 57 | 43 | 3 | CID000001908 | |
| Drug | RH-3421 | 1.90e-04 | 11 | 43 | 2 | CID000108039 | |
| Drug | chloroacetylajmaline | 1.90e-04 | 11 | 43 | 2 | CID000038681 | |
| Drug | U46619 | 1.94e-04 | 285 | 43 | 5 | CID000005618 | |
| Drug | procaine | 1.97e-04 | 153 | 43 | 4 | CID000004914 | |
| Drug | Ado-5'-PP[S | 1.99e-04 | 60 | 43 | 3 | CID005310995 | |
| Drug | prasugrel | 2.09e-04 | 61 | 43 | 3 | CID006918456 | |
| Drug | 8-phenyltheophylline | 2.20e-04 | 62 | 43 | 3 | CID000001922 | |
| Drug | methylglucamine | 2.20e-04 | 62 | 43 | 3 | CID000004049 | |
| Drug | acetophenone | 2.27e-04 | 12 | 43 | 2 | ctd:C038699 | |
| Drug | Ro 22-9194 | 2.27e-04 | 12 | 43 | 2 | CID000129209 | |
| Drug | resiniferatoxin | 2.64e-04 | 66 | 43 | 3 | CID000104826 | |
| Drug | Up4dC | 2.68e-04 | 13 | 43 | 2 | CID000192707 | |
| Drug | 2-MeSAMP | 2.68e-04 | 13 | 43 | 2 | CID000189762 | |
| Drug | NSC-53396 | 2.68e-04 | 13 | 43 | 2 | CID000037595 | |
| Drug | CID6432355 | 2.68e-04 | 13 | 43 | 2 | CID006432355 | |
| Drug | AC1LCJM3 | 2.68e-04 | 13 | 43 | 2 | CID000631640 | |
| Drug | carbachol | 2.79e-04 | 688 | 43 | 7 | CID000002551 | |
| Drug | gabapentin | 2.88e-04 | 169 | 43 | 4 | CID000003446 | |
| Drug | verapamil | 2.99e-04 | 490 | 43 | 6 | CID000002520 | |
| Drug | A3P5PS | 3.13e-04 | 14 | 43 | 2 | CID005310943 | |
| Drug | lorcainide | 3.13e-04 | 14 | 43 | 2 | CID000042883 | |
| Drug | octylguanidine | 3.13e-04 | 14 | 43 | 2 | CID000030621 | |
| Drug | Digocin | 3.14e-04 | 70 | 43 | 3 | CID000003062 | |
| Drug | riluzole | 3.22e-04 | 174 | 43 | 4 | CID000005070 | |
| Drug | flecainide | 3.28e-04 | 71 | 43 | 3 | CID000003355 | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 3.37e-04 | 176 | 43 | 4 | 6179_DN | |
| Drug | 3'-AMP | 3.42e-04 | 72 | 43 | 3 | CID000041211 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 3.51e-04 | 178 | 43 | 4 | 6193_DN | |
| Drug | AC1NE3N8 | 3.51e-04 | 178 | 43 | 4 | CID004636050 | |
| Drug | sotalol | 3.56e-04 | 73 | 43 | 3 | CID000005253 | |
| Drug | carbamazepine | 3.59e-04 | 179 | 43 | 4 | CID000002554 | |
| Drug | trimethyloxonium | 3.60e-04 | 15 | 43 | 2 | CID000093245 | |
| Drug | AC1L1W4O | 3.60e-04 | 15 | 43 | 2 | CID000036625 | |
| Drug | HFBA | 3.60e-04 | 15 | 43 | 2 | CID000067643 | |
| Drug | Catecholamines | 3.60e-04 | 15 | 43 | 2 | ctd:D002395 | |
| Drug | adenine | 3.70e-04 | 510 | 43 | 6 | CID000000190 | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.98e-04 | 184 | 43 | 4 | 4369_UP | |
| Drug | AC1N5WL5 | 4.01e-04 | 76 | 43 | 3 | CID004250634 | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | 4.07e-04 | 185 | 43 | 4 | 2338_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 4.41e-04 | 189 | 43 | 4 | 1285_UP | |
| Drug | ATP,Gamma S | 4.41e-04 | 189 | 43 | 4 | CID000002028 | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 4.59e-04 | 191 | 43 | 4 | 7088_UP | |
| Drug | articaine | 4.65e-04 | 17 | 43 | 2 | CID000032169 | |
| Drug | PPNDS | 4.65e-04 | 17 | 43 | 2 | CID005961627 | |
| Drug | lifarizine | 4.65e-04 | 17 | 43 | 2 | CID000071336 | |
| Drug | sumatriptan | 4.66e-04 | 80 | 43 | 3 | CID000005358 | |
| Drug | Adenosine Triphosphate | 4.77e-04 | 193 | 43 | 4 | ctd:D000255 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; PC3; HT_HG-U133A | 4.86e-04 | 194 | 43 | 4 | 4248_DN | |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 4.96e-04 | 195 | 43 | 4 | 4402_UP | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; PC3; HT_HG-U133A | 5.05e-04 | 196 | 43 | 4 | 4225_UP | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.05e-04 | 196 | 43 | 4 | 5807_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; MCF7; HT_HG-U133A | 5.05e-04 | 196 | 43 | 4 | 6501_UP | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; PC3; HT_HG-U133A | 5.05e-04 | 196 | 43 | 4 | 4317_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; PC3; HT_HG-U133A | 5.15e-04 | 197 | 43 | 4 | 4668_UP | |
| Drug | CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A | 5.15e-04 | 197 | 43 | 4 | 6412_UP | |
| Drug | Pivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | 5.15e-04 | 197 | 43 | 4 | 5046_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Up 200; 17uM; PC3; HT_HG-U133A | 5.15e-04 | 197 | 43 | 4 | 6322_UP | |
| Drug | moricizine | 5.23e-04 | 18 | 43 | 2 | CID000034632 | |
| Drug | Scorpion Venoms | 5.23e-04 | 18 | 43 | 2 | ctd:D012604 | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.25e-04 | 198 | 43 | 4 | 6033_UP | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 5.25e-04 | 198 | 43 | 4 | 2293_UP | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 5.25e-04 | 198 | 43 | 4 | 6328_UP | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A | 5.35e-04 | 199 | 43 | 4 | 3101_UP | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 5.35e-04 | 199 | 43 | 4 | 3097_UP | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 5.35e-04 | 199 | 43 | 4 | 4666_UP | |
| Drug | Sodium | 5.37e-04 | 84 | 43 | 3 | ctd:D012964 | |
| Drug | forskolin from Coleus forskohlii | 5.41e-04 | 1013 | 43 | 8 | CID000003413 | |
| Drug | N6-Me-dAdo | 5.84e-04 | 19 | 43 | 2 | CID000168948 | |
| Drug | diprafenone | 5.84e-04 | 19 | 43 | 2 | CID000071249 | |
| Drug | menthol | 5.95e-04 | 87 | 43 | 3 | CID000001254 | |
| Drug | reactive blue 2 | 5.95e-04 | 87 | 43 | 3 | CID000656725 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.04e-10 | 10 | 40 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.04e-10 | 10 | 40 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.42e-09 | 12 | 40 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 1.79e-06 | 2 | 40 | 2 | C4551549 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.49e-06 | 22 | 40 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | B Virus Infection | 5.37e-06 | 3 | 40 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 5.37e-06 | 3 | 40 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 5.37e-06 | 3 | 40 | 2 | C0019372 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 4.99e-05 | 8 | 40 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 4.99e-05 | 8 | 40 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 4.99e-05 | 8 | 40 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 4.99e-05 | 8 | 40 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 4.99e-05 | 8 | 40 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 4.99e-05 | 8 | 40 | 2 | C0393703 | |
| Disease | Myoclonic Epilepsy | 6.41e-05 | 9 | 40 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 6.41e-05 | 9 | 40 | 2 | C3502809 | |
| Disease | epilepsy (implicated_via_orthology) | 7.02e-05 | 163 | 40 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Epilepsy, Myoclonic, Infantile | 8.01e-05 | 10 | 40 | 2 | C0917800 | |
| Disease | Myoclonic Astatic Epilepsy | 9.78e-05 | 11 | 40 | 2 | C0393702 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.38e-04 | 13 | 40 | 2 | C0751122 | |
| Disease | Asthma | 1.76e-04 | 80 | 40 | 3 | C0004096 | |
| Disease | diverticular disease | 2.91e-04 | 236 | 40 | 4 | EFO_0009959 | |
| Disease | Epilepsy | 4.39e-04 | 109 | 40 | 3 | C0014544 | |
| Disease | Grey matter density measurement | 9.78e-04 | 34 | 40 | 2 | EFO_0010306 | |
| Disease | shoulder impingement syndrome | 1.10e-03 | 36 | 40 | 2 | EFO_1001178 | |
| Disease | asthma (is_implicated_in) | 1.26e-03 | 157 | 40 | 3 | DOID:2841 (is_implicated_in) | |
| Disease | osteoarthritis, knee | 1.29e-03 | 158 | 40 | 3 | EFO_0004616 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CFSPILYAFSSHRFR | 306 | O00590 | |
| PEHSLFFFCSRKARI | 76 | Q8N8Q1 | |
| LHEAVRFSFAFSFPR | 51 | Q4KMX7 | |
| VLIIFLVCFTPFHAR | 246 | Q99678 | |
| RFLQAFFISHCLPRA | 361 | P80365 | |
| PAIAHFCSLFRTAFR | 21 | Q9BXF3 | |
| FRSPVFRIFFHKIFI | 326 | Q13258 | |
| FPLFLQHPFRRHLCF | 191 | Q86XR2 | |
| FALIQLPRFHIFFLV | 1241 | Q9NRD9 | |
| LHEAVRFSFAFSFPR | 51 | P0CH98 | |
| KFHSIVRLVAFCPFA | 41 | O00567 | |
| HPFFFRTRACDLLLQ | 176 | Q8NFM7 | |
| RFRFARKPFCVIDFI | 166 | P56696 | |
| FTPVDFHYIRNRACF | 41 | Q9H1B4 | |
| PLFCWIIFRCFQHFR | 391 | Q9Y239 | |
| ACRFFHFRRLIFTRK | 936 | Q7LBC6 | |
| IIAVFFICFVPFHFA | 241 | Q9H244 | |
| FICFVPFHFARIPYT | 246 | Q9H244 | |
| LAVFALCFLPFHVTR | 251 | P41231 | |
| VAVFFVCFAPFHFAR | 261 | Q9BPV8 | |
| QKDSPVFCRFFHFRR | 561 | Q9Y4C1 | |
| TRFFTFHFILPFIIA | 176 | P00156 | |
| FCFLVHIDLPLFFPR | 306 | Q9NXR7 | |
| SRLQRHFCVFAVSFP | 2581 | Q9UFH2 | |
| AFHFLNRFPSVYLRC | 2346 | Q9UGM3 | |
| HFVASVFRGFFRIIC | 4296 | Q92736 | |
| RLCFPRFFFVSDPAL | 1711 | Q8TE73 | |
| HSLFQTSFVFRLPFC | 176 | Q8NH81 | |
| LRISINTFCRAFPFH | 316 | P33402 | |
| FRRHFPVLFVSACLF | 386 | Q8WU17 | |
| AAESHFLRVFLFFRP | 11 | Q9Y2Q9 | |
| DFFHSFLIVFRILCG | 746 | P35499 | |
| NDFFHSFLIVFRVLC | 911 | Q15858 | |
| FASLLRFHQFHPFLC | 51 | Q9Y274 | |
| RFHQFHPFLCAADFR | 56 | Q9Y274 | |
| DFFHSFLIVFRVLCG | 936 | P35498 | |
| PFLHFIIFLFTLRCL | 1206 | O94911 | |
| VQLRHCLGVFFPVFA | 746 | Q9BPX3 | |
| FHCGFRRFRASPLFS | 616 | Q2NL82 | |
| LFHIFCFLFCTGEIR | 1016 | O75762 | |
| FHVLHQRFPLFTFRV | 2486 | O60673 | |
| LLFAVHSFRPAPFFV | 1136 | Q8NDV3 | |
| ARARAFFTAPVVVFH | 786 | O94759 | |
| FFRRHYPLNTVTFCD | 1656 | Q9HBL0 | |
| DFFHSFLIVFRVLCG | 921 | Q9UQD0 | |
| CFFFLLLQRRVFLSH | 1291 | Q92508 |